Skip to content

Development of novel cytologic sampling device for cervical cancer screening

Development of novel cytologic sampling device for cervical cancer screening - Development of novel cytologic sampling device for cervical cancer screening

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031303
Enrollment
140
Registered
2018-02-14
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer and cervical precursor lesion

Interventions

Existing device(Cervex)/Existing device(Cervex) New device/Existing device(Cervex) New device/Existing device(cotton swab) New device/Existing device(YUINO BRUSH)

Sponsors

Hamamatsu University School of Medicine
Lead Sponsor
Neuroceuticals
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients aged 20 years or older, patients scheduled to undergo cervical cytology diagnosis, patients who obtained their consent by written document

Exclusion criteria

Exclusion criteria: Patients who doctor judged inappropriate for participation in this study

Design outcomes

Primary

MeasureTime frame
Adverse event at cell collection and measurement the amount of collected cells

Secondary

MeasureTime frame
Evaluate appropriateness of specimens and symptoms such as bleeding and pain

Countries

Japan

Contacts

Public ContactToshiaki Shibata

Hamamatsu University School of Medicine Obstetrics and gynecology

tshibata@hama-med.ac.jp053-435-2309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026